Sarah Jury

Robert A. Clark, MD, Ashbel Smith Professor of Medicine and Associate Vice President for Translational Science at UT Health San Antonio, has been selected as the 2026 BioMedSA BioMedSA Research Innovation Award recipient. The honor recognizes his five decades of groundbreaking discoveries and his transformational leadership in building San Antonio’s biomedical research infrastructure. Dr. Clark’s … Read more

Championing the biomedical industry and its contributions to the lives of the citizens of San Antonio, BioMedSA has selected its 2026 Entrepreneur Award recipient. BioMedSA named Dr. James R. “Jim” Leininger as this year’s honoree, recognizing a physician‑innovator whose work transformed wound care, strengthened the region’s biomedical economy, and helped define San Antonio’s identity as … Read more

BioMedSA’s Board of Directors approved 2 new memberships in April 2026:  Rees Scientific and Rogel Associates. Rees Scientific provides automated environmental monitoring systems designed to continuously track critical conditions such as temperature, humidity, differential pressure, CO₂ levels, and other environmental variables. These systems are commonly used in regulated environments where maintaining stable conditions is essential … Read more

BioMedSA’s Board of Directors approved 3 new memberships in February 2026: Cardivox AI, Joeris General Contractors, and TruCells. Cardivox AI is developing an AI‑driven platform designed to analyze cardiovascular health using ECG and heart‑rate data. The system incorporates machine‑learning algorithms to estimate metrics such as blood pressure and identify potential cardiac risks. It integrates with … Read more

Lori Boies, Ph.D., MPH, has made significant contributions to the fields of bioinformatics, cancer biology, public health, and science education. Her early research at UT Southwestern advanced neuro-oncology by developing and characterizing two novel inducible transgenic mouse models, leading to the identification of distinct populations of adult neural stem cells and transient progenitors that persist … Read more

Medical genomics plays an increasingly important role in the life sciences, informing advances in research, diagnostics, and therapeutic development.  By examining how genetic variation influences disease risk, treatment response, and health outcomes, genomics is transforming how biomedical research is conducted and how new diagnostics and therapies are developed.  What was once confined to specialized research … Read more

BioMedSA’s Board of Directors approved 5 new memberships in January 2026: Bürkert Fluid Control Systems, Hard Rock Cafe, Hilton Palacio del Rio, McFalls Associates and Visit San Antonio.   Bürkert Fluid Control Systems specializes in precise fluid measurement and control technologies used across a variety of technical applications. Their products support environments where accuracy, durability, … Read more

BioMedSA’s Board of Directors approved 5 new memberships in November 2025: BleedIO, ClearCam, DIRTT, Julie Riegel and QRx Partners.   BleedIO delivers SaaS and HaaS solutions using BLE Mesh, a wireless technology designed for decentralized networks that operate without internet or centralized systems. Proprietary technology improves uptime, resiliency, and security for IoT. Device-to-device (D2D) communication … Read more

NetSuite seeks to help organizations increase productivity, improve efficiencies, and provide the visibility and control needed to run successful businesses by providing an integrated system that includes financials/Enterprise Resource Planning (ERP), inventory management, HR, professional services automation, and omnichannel commerce. With cross-industry expertise, NetSuite can be tailored to meet the specific needs of the industry … Read more